Project Syndicate: Cancer Care for the Developing World
Lawrence N. Shulman, chief of staff and director of the Center for Global Cancer Medicine at the Dana-Farber Cancer Institute, Harvard Medical School

“…[S]teady progress has been made using chemotherapy, surgery, and radiation to treat and cure an increasing number of cancer patients. But access to these life-saving advances remains elusive in low- and middle-income countries, where the majority of cancer patients reside today. … The most efficient approach to reducing global cancer mortality rates would be to bring existing therapies to cancer patients in developing countries. Add to that international funding for cancer treatment, like that which was mobilized for HIV/AIDS through the U.S. President’s Emergency Plan for AIDS Relief and the Global Fund, and cancer mortality rates in developing countries could decline considerably — and quickly… (2/2).